These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3079799)

  • 41. Suppression of cell-mediated tumor cell lysis and complement-induced cytotoxicity by trypan blue.
    Scornik JC; Ruiz P; Hoffman EM
    J Immunol; 1979 Sep; 123(3):1278-84. PubMed ID: 469250
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cell-mediated and glucocorticoid-mediated target cell lysis do not appear to share common pathways.
    Dennert G; Landon C; Nowicki M
    J Immunol; 1988 Aug; 141(3):785-91. PubMed ID: 3260911
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cytotoxic T lymphocytes induce different types of DNA damage in target cells of different origins.
    Sellins KS; Cohen JJ
    J Immunol; 1991 Aug; 147(3):795-803. PubMed ID: 1861075
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Involvement of two distinct killing mechanisms in bystander target cell lysis induced by a cytotoxic T lymphocyte clone.
    Kuwano K; Arai S
    Cell Immunol; 1996 May; 169(2):288-93. PubMed ID: 8620557
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Proteinases are involved in both DNA fragmentation and membrane damage during CTL-mediated target cell killing.
    Helgason CD; Atkinson EA; Pinkoski MJ; Bleackley RC
    Exp Cell Res; 1995 May; 218(1):50-6. PubMed ID: 7737379
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Studies on the mechanism of natural killer cell-mediated cytotoxicity. V. Lack of NK specificity at the level of induction of natural killer cytotoxic factors in cultures of human, murine, or rat effector cells stimulated with mycoplasma-free cell lines.
    Wright SC; Bonavida B
    J Immunol; 1984 Dec; 133(6):3415-23. PubMed ID: 6491292
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Target cell recognition structures in LDCC and ODCC.
    Gorman KC; Kane KP; Clark WR
    J Immunol; 1987 Feb; 138(4):1014-9. PubMed ID: 3100625
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The third component of complement (C3) bound to tumor target cells enhances their sensitivity to killing by activated macrophages.
    Bara S; Lint TF
    J Immunol; 1987 Feb; 138(4):1303-9. PubMed ID: 3100634
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Distinct restriction of complement- and cell-mediated lysis.
    Hollander N; Shin ML; Rosse WF; Springer TA
    J Immunol; 1989 Jun; 142(11):3913-6. PubMed ID: 2785570
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Autochthonous, allogeneic, and exenogeneic cells as targets for vaccinia immune lymphocyte cytotoxicity.
    Woan MC; Yip DM; Tompkins WA
    J Immunol; 1978 Jan; 120(1):312-6. PubMed ID: 627720
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The mechanism of T-cell mediated cytotoxicity. VII. Lysis of isolated cytoplasts and karyoplasts.
    Sanderson CJ; Thomas JA
    Immunology; 1979 Jun; 37(2):373-6. PubMed ID: 112045
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antibody-dependent human lymphocytotoxicity: a micro assay system.
    Zeijlemaker WP; Roos MT; Schellekens PT; Eijsvoogel VP
    Eur J Immunol; 1975 Aug; 5(8):579-84. PubMed ID: 824141
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Studies on the mechanism of lymphocyte-mediated cytolysis. V. The use of cytochalasins A and B to dissociate glucose transport from the lytic event.
    Bubbers JE; Henney CS
    J Immunol; 1975 Jul; 115(1):145-49. PubMed ID: 807622
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antibody-dependent cell-mediated damage of target cells.
    Scornik JC; Klein PA
    Transplantation; 1978 Nov; 26(5):356-7. PubMed ID: 100916
    [No Abstract]   [Full Text] [Related]  

  • 55. Interruption of the sequential release of small and large molecules from tumor cells by low temperature during cytolysis mediated by immune T-cells or complement.
    Martz E; Burakoff SJ; Benacerraf B
    Proc Natl Acad Sci U S A; 1974 Jan; 71(1):177-81. PubMed ID: 4359327
    [TBL] [Abstract][Full Text] [Related]  

  • 56. P815 mastocytoma cells, classical targets for cytotoxic T lymphocytes, exert natural cytotoxicity.
    Luciani MF; Brunet JF; Denizot F; Golstein P
    Ann Inst Pasteur Immunol; 1987; 138(1):37-43. PubMed ID: 3107589
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lack of lymphocyte-induced DNA fragmentation in human targets during lysis represents a species-specific difference between human and murine cells.
    Christiaansen JE; Sears DW
    Proc Natl Acad Sci U S A; 1985 Jul; 82(13):4482-5. PubMed ID: 3874402
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cytotoxic activity of human lymphocyte plasma membranes.
    Ferluga J; Friou GJ; Allison AC
    Clin Exp Immunol; 1976 Aug; 25(2):347-51. PubMed ID: 821684
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The interaction of activated macrophages with normal and neoplastic cells.
    La Posta VJ; Kotlarski I
    Aust J Exp Biol Med Sci; 1982 Oct; 60 (Pt 5)():513-28. PubMed ID: 6819844
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Marking hypoxic cells for complement and cytotoxic T lymphocyte-mediated lysis: using pimonidazole.
    Chou SC; Flood PM; Raleigh JA
    Br J Cancer Suppl; 1996 Jul; 27():S213-6. PubMed ID: 8763883
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.